NCT04347174 - A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2020

Primary Completion Date

August 10, 2020

Study Completion Date

August 21, 2020

Conditions

COVID-19

Interventions

DRUG

Suspension of heat killed (autoclaved) Mycobacterium w

Patients will be randomized to receive either Mycobacterium w in combination with standard care as per hospital practice or standard care alone in COVID-19 as per hospital practice.

DRUG

Placebo

All patients will continue to receive standard therapy as per hospital practice till considered requisite by the treating physician

Trial Locations (4)

110029

All lndia Institute of Medical Science, Delhi, Delhi

160012

Postgraduate Institute of Medical Education and Research, Chandigarh

462024

All India Institute of Medical Sciences, Bhopal, Bhopal

492099

All India Institute of Medical Science, Raipur, Raipur